Is MMP-7 gene polymorphism a possible risk factor for chronic obstructive pulmonary disease in Turkish patients

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 6, 2012, Pages 519-523

  Mogulkoc, Umit ^a   Coskunpinar, Ender ^b   Aynaci, Engin ^a   Caǧlar, Emel ^a   Ortakoylu, Mediha Gonenc ^a   Ozkan, Gokhan ^b   Oltulu, Yasemin Musteri ^b   Eraltan, Ilhan Yaylim ^b  

^a Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE ELASTASE; MATRILYSIN;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); WILD TYPE;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 84863000683     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0271     Document Type: Article

References (37)

1. Babusyte A, Stravinskaite K, Jeroch J, et al. (2007) Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res 14:8-81.
2. Barnes PJ (2004) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56:515-548.
3. Belvisi MG, Bottomley KM (2003) The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm Res 52:95-100. (Pubitemid 36470068)
4. Burke B (2005) The role of matrix metalloproteinase 7 in innate immunity. Immunobiology 209:755. [Review].
5. Burke B, Giannoudis A, Corke KP, et al. (2003) Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163:1233-1243. (Pubitemid 37175073)
6. Cheng SL, Yu CJ, Yang PC (2009) Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease. Biochem Genet 47:591-601.
7. Demedts IK, Brusselle GG, Bracke KR, et al. (2005) Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 3:257-263. (Pubitemid 40674248)
8. Dunsmore SE, Saarialho-Kere UK, Roby JD, et al. (1998) Matrilysin expression and function in airway epithelium. J Clin Invest 102:1321-1331. (Pubitemid 28467560)
9. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174. (Pubitemid 37328786)
10. Elander N, Söderkvist P, Fransén K (2006) Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26:791-795. (Pubitemid 43206050)
11. Elkington PT, Friedland JS (2006) Matrix metalloproteinases in destructive pulmonary pathology. Thorax 61:259-266.
12. Finlay GA, Russell KJ, McMahon KJ, et al. (1997) Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52:502-506. (Pubitemid 27298499)
13. Ghilardi G, Biondi ML, Erario M, et al. (2003) Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 49:1940-1942. (Pubitemid 37340333)
14. Haq I, Chappell S, Johnson SR, et al. (2010) Association of MMP- 2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Med Genet 15:11-17.
15. Hersh CP, Demeo DL, Lange C, et al. (2005) Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 33:71-78. (Pubitemid 40961016)
16. Ito I, Nagai S, Handa T, et al. (2005) Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 172:1378-1382. (Pubitemid 43069810)
17. Joos L, He JQ, Shepherdson MB, et al. (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 5:569-576. (Pubitemid 34257493)
18. Jormsjö S, Ye S, Moritz J, et al. (2000) Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res 86:998-1003. (Pubitemid 30324313)
19. Kinnula VL (2005) Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60:693-700.
20. Kosaka Y, Mimori K, Fukagawa T, et al. (2011) Clinical significance of molecular detection of matrix etalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer. Ann Surg Oncol [Epub ahead of print] PubMed PMID: 21761103.
21. Lee SY, Kim MJ, Kang HG, et al. (2010) Polymorphisms in matrix metalloproteinase-1, -9 and -12 genes and the risk of chronic obstructive pulmonary disease in a Korean population. Respiration 80:133-138.
22. Li Y, Jin X, Kang S, et al. (2006) Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. GynecolOncol 101:92-96.
23. Lohi J, Wilson CL, Roby JD, et al. (2001) Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 276: 10134-10144.
24. Minematsu N, Nakamura H, Tateno H, et al. (2001) Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 289:116-119. (Pubitemid 33108801)
25. Ohnishi K, Takagi M, Kurokawa Y, et al. (1998) Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 78: 1077-1087. (Pubitemid 28440824)
26. Retamales I, Elliott WM, Meshi B, et al. (2001) Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 164:469-673.
27. Saitoh W, Sakamoto T, Hegab AE, et al. (2006) MMP14 gene polymorphisms in chronic obstructive pulmonary disease. Int J Mol Med 17:621-626.
28. Schirmer H, Basso da Silva L, Teixeira PJ, et al. (2009) Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population. Genet Mol Res 8:1028-1034.
29. Segura-Valdez L, Pardo A, Gaxiola M, et al. (2000) Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117:684-694. (Pubitemid 30152206)
30. Shapiro SD (1998) Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 10:602-608.
31. Shapiro SD, Campbell EJ, Welgus HG, et al. (1991) Elastin degradation by mononuclear phagocytes. Ann N Y Acad Sci 624:69-80.
32. Silverman EK, Weiss ST, Drazen JM, et al. (2000) Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:2152-2158. (Pubitemid 32051679)
33. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516. [Review]. (Pubitemid 33096184)
34. Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623-629.
35. Yoshida T, Tuder RM (2007) Pathobiology of cigarette smokeinduced chronic obstructive pulmonary disease. Physiol Rev 87:1047-1082. (Pubitemid 47084676)
36. Yu C, Zhou Y, Miao X, et al. (2004) Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 64:7622-7628. (Pubitemid 39372109)
37. Zhou M, Huang SG, Wan HY, et al. (2004) Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China. Chin Med J (Engl) 117:1481-1484. (Pubitemid 39530225)